MGX
Metagenomi, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$53.08M
P/E Ratio
—
EPS
$-2.41
Beta
0.65
52W High
$3.95
52W Low
$1.25
50-Day MA
$1.46
200-Day MA
$1.86
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Metagenomi, Inc. Common Stock
Metagenomi, Inc., a gene editing biotechnology company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. The company is headquartered in Emeryville, California.
Fundamentals
| Revenue (TTM) | $25.21M |
| Gross Profit (TTM) | $-69.22M |
| EBITDA | $-90.70M |
| Operating Margin | -623.00% |
| Return on Equity | -44.70% |
| Return on Assets | -22.00% |
| Revenue/Share (TTM) | $0.68 |
| Book Value | $4.22 |
| Price-to-Book | 0.33 |
| Price-to-Sales (TTM) | 2.11 |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -59.30% |
| Shares Outstanding | $37.65M |
| Float | $27.32M |
| % Insiders | 19.25% |
| % Institutions | 20.12% |
Historical Volatility
HV 10-Day
50.77%
HV 20-Day
41.36%
HV 30-Day
44.67%
HV 60-Day
61.14%
HV Rank
2.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($9.33 target)
4
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/5/2026